Literature DB >> 22735028

Illicit drug use, hypertension, and chronic kidney disease in the US adult population.

Sanjeev K Akkina1, Ana C Ricardo, Amishi Patel, Arjun Das, Lydia A Bazzano, Carolyn Brecklin, Michael J Fischer, James P Lash.   

Abstract

Illicit drug use has been associated with chronic kidney disease (CKD) in select populations, but it is unknown whether the same association exists in the general population. By using data from the National Health and Nutrition Examination Survey 2005-2008, we conducted a cross-sectional analysis of 5861 adults who were questioned about illicit drug use, including cocaine, methamphetamines, and heroin, during their lifetime. The primary outcome was CKD as defined by an estimated glomerular filtration rate ≤60 mL/min/1.73 m(2) using the Chronic Kidney Disease Epidemiology Collaboration equation or by microalbuminuria. We also examined the association between illicit drug use and blood pressure (BP) ≥120/80, ≥130/85, and ≥140/90 mm Hg. Logistic regression was used to examine the association between illicit drug use and CKD and BP. Mean estimated glomerular filtration rate was similar between illicit drug users and nonusers (100.7 vs 101.4 mL/min/1.73 m(2), P = 0.4), as was albuminuria (5.7 vs 6.0 mg/g creatinine, P = 0.5). Accordingly, illicit drug use was not significantly associated with CKD in logistic regression models (odds ratio [OR], 0.98; confidence interval [CI], 0.75-1.27) after adjusting for other important factors. However, illicit drug users had higher systolic (120 vs 118 mm Hg, P = 0.04) and diastolic BP (73 vs 71 mm Hg, P = 0.0003) compared with nonusers. Cocaine use was independently associated with BP ≥130/85 mm Hg (OR, 1.24; CI, 1.00-1.54), especially when used more during a lifetime (6-49 times; OR, 1.42; CI, 1.06-1.91). In a representative sample of the US population, illicit drug use was not associated with CKD, but cocaine users were more likely to have elevated BP.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735028      PMCID: PMC3461092          DOI: 10.1016/j.trsl.2012.05.008

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  40 in total

1.  Prevalence of renal disease in asymptomatic heroin addicts.

Authors:  J A Arruda; N A Kurtzman; V K Pillay
Journal:  Arch Intern Med       Date:  1975-04

2.  Acute renal failure after ecstasy.

Authors:  I H Fahal; D F Sallomi; M Yaqoob; G M Bell
Journal:  BMJ       Date:  1992-07-04

3.  Kidney vascular damage and cocaine.

Authors:  N Di Paolo; V Fineschi; M Di Paolo; C V Wetly; G Garosi; M T Del Vecchio; G Bianciardi
Journal:  Clin Nephrol       Date:  1997-05       Impact factor: 0.975

4.  Cardiovascular Effects of Cocaine: Focus on Hypertension.

Authors:  Carolyn S. Brecklin; Jerry L. Bauman
Journal:  J Clin Hypertens (Greenwich)       Date:  1999-11       Impact factor: 3.738

5.  Natural history of heroin-associated nephropathy.

Authors:  T K Rao; A D Nicastri; E A Friedman
Journal:  N Engl J Med       Date:  1974-01-03       Impact factor: 91.245

6.  Cocaine use, hypertension, and end-stage renal disease.

Authors:  K C Norris; M Thornhill-Joynes; C Robinson; T Strickland; B L Alperson; S C Witana; H J Ward
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

7.  Prevalence of hypertension in chronic cocaine users.

Authors:  C S Brecklin; A Gopaniuk-Folga; T Kravetz; S Sabah; A Singh; J A Arruda; G Dunea
Journal:  Am J Hypertens       Date:  1998-11       Impact factor: 2.689

8.  Renal infarction associated with intravenous cocaine use.

Authors:  J A Sharff
Journal:  Ann Emerg Med       Date:  1984-12       Impact factor: 5.721

9.  Rhabdomyolysis and shock after intravenous amphetamine administration.

Authors:  W C Kendrick; A R Hull; J P Knochel
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

10.  Left ventricular hypertrophy associated with chronic cocaine abuse.

Authors:  M E Brickner; J E Willard; E J Eichhorn; J Black; P A Grayburn
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

View more
  10 in total

1.  Reversibility of myocardial hypertrophy 8 years after adrenal adenoma excision and drugs and alcohol addiction withdrawal.

Authors:  Gian Piero Carboni
Journal:  BMJ Case Rep       Date:  2013-05-13

Review 2.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

3.  Lifetime Cocaine and Opiate Use and Chronic Kidney Disease.

Authors:  Tessa Novick; Yang Liu; Anika Alvanzo; Alan B Zonderman; Michele K Evans; Deidra C Crews
Journal:  Am J Nephrol       Date:  2016-10-28       Impact factor: 3.754

Review 4.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

5.  Amphetamine-induced sensitization of hypertension and lamina terminalis neuroinflammation.

Authors:  Seth W Hurley; Terry G Beltz; Fang Guo; Baojian Xue; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-02-12       Impact factor: 3.619

Review 6.  Cocaine and kidney injury: a kaleidoscope of pathology.

Authors:  Narender Goel; James M Pullman; Maria Coco
Journal:  Clin Kidney J       Date:  2014-09-12

Review 7.  Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.

Authors:  Feyza Bora; Fatih Yılmaz; Taner Bora
Journal:  Iran J Basic Med Sci       Date:  2016-11       Impact factor: 2.699

8.  Effect of substance use on premature mortality among severely hypertensive African Americans.

Authors:  Vinithra Varadarajan; Chidinma A Ibe; J Hunter Young
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-07       Impact factor: 3.738

Review 9.  Substance use among adolescents and young adults with chronic kidney disease or kidney failure.

Authors:  Nianzhou Xiao; Hua Chai; Abiodun Omoloja
Journal:  Pediatr Nephrol       Date:  2021-03-09       Impact factor: 3.714

10.  Comparing Medical Comorbidities Between Opioid and Cocaine Users: A Data Mining Approach.

Authors:  Yong-Mi Kim
Journal:  Addict Health       Date:  2019-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.